Fast vs. slow: which oral allergy treatment works best for kids?
NCT ID NCT06976775
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two ways of giving oral immunotherapy to children aged 6–16 with milk or egg allergy. One method uses daily increasing doses over a week ('rush'), while the other uses doses every two weeks ('conventional'). The goal is to see which is safer and more effective at helping children tolerate these foods, and to find biological markers that predict success.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
oral immunotherapy (milk or egg protein)
What this could lead to
If successful, this could identify a safer, more efficient way to desensitize children to milk or egg, reducing allergic reactions from accidental exposure.
What could go wrong
This is a small, early-phase trial (Phase 2/3) with only 40 children. The faster 'rush' regimen may cause more side effects, and results may not apply to all allergic children.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOOD ALLERGY IN CHILDREN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Infantil Universitario Niño Jesús. Avenida de Menéndez Pelayo, número 65
RECRUITINGMadrid, 28009, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••